In the news / Precision Medicine

NEWS
In this episode, hosts Brooke Moreno and Sean Cadin talk with Dr. Bonnie LaFleur about her upcoming Precision Wellness in the Time of COVID-19 lecture on March 15, 2021.
 
NEWS
In this episode of Science Talks, Brooke Moreno and Sean Cadin talk with Precision Nutrition and Wellness Director Dr. Floyd "Ski" Chilton about the upcoming Precision Wellness in the Time of COVID-19 series.
 
NEWS
In this episode of Science Talks, Brooke Moreno and Sean Cadin talk with BIO5 COVID-19 seed grant awardee Dr. Jianqin Lu about his two treatment-based COVID-19 projects.
 
NEWS
The third annual BIO5 Postdoctoral Fellowship, this year awarded to eight outstanding postdoctoral researchers, grants financial support and facilitates guidance to enrich research and career growth.
 
NEWS
The University of Arizona College of Medicine has named Dr. Monica Kraft the new contact principal investigator for the University of Arizona’s Banner Health All of Us Research Program. Dr. Kraft will be responsible for leading the program’s efforts to ensure diverse populations are well represented in the national All of Us database. The program’s mission is to inform thousands of research studies that cover a wide variety of health conditions.
 
NEWS
Dr. Judith Su runs the UArizona Little Sensor Lab, where researchers are working to sense tiny amounts – down to a single molecule – of everything from doping agents to biomarkers for cancer, Alzheimer's disease, Lyme disease and, yes, even COVID-19. Dr. Su, biomedical engineering and optical sciences professor and a member of the BIO5 Institute, has received a $1.82 million, five-year Maximizing Investigators' Research Award from the National Institute of General Medical Sciences, which is part of the National Institutes of Health.
 
NEWS
On campus at the University of Arizona, researchers are trying to crack the cancer code. With the help of a grant from the American Cancer Society Dr. Jacob Schwartz, BIO5 member and assistant professor in the Department of Chemistry and Biochemistry, is taking a closer look at the the behavior of the childhood cancer, Ewing Sarcoma. Dr. Schwartz also says it is helping them understand other cancers along the way.
 
NEWS
SARS-CoV-2, the virus that causes COVID-19, can relieve pain, according to a new study by University of Arizona researchers. The finding may explain why nearly half of all people who get COVID-19 experience few or no symptoms, even though they are able to spread the disease, according to the study's corresponding author Dr. Rajesh Khanna, UArizona College of Medicine – Tucson's Department of Pharmacology professor and member of the BIO5 Institute.
 
NEWS
Sinus infections are one of the most common illnesses, so identifying the progression of the common cold to chronic disease lasting longer than 12 weeks is critical in creating therapies that slow the development of a disease affecting nearly 12% of U.S. adults each year. A group lead by Dr. Eugene Chang, vice chair and associate professor in the Department of Otolaryngology-Head and Neck Surgery at the UArizona College of Medicine, was awarded $2.24 million to study a protein in the respiratory tract with a genetic variation strongly associated with these ailments.
 
NEWS
Endometriosis is a chronic, often painful, gynecological disorder affecting 15% of U.S. women of childbearing age. This condition often causes higher incidences of infertility, miscarriage and stroke. Dr. Leslie V. Farland of the Mel and Enid Zuckerman College of Public Health has been awarded federal funding from the National Institutes of Health to study the association among endometriosis, infertility and risk of stroke.
 
NEWS
Innovative minds spanning several disciplines created partnerships to advance research and impact the lives of Arizonans at the second annual BIO5/BIOSA Faculty Industry Networking Event.
 
NEWS
In the case of colorectal cancer, the detection of early metastases to the liver is crucial for patient survival. A University of Arizona Health Sciences research team featuring Dr. Ali Bilgin is developing a novel imaging technique to detect the spread of colorectal cancer. The group aims to provide better outcomes for patients through the use of novel MRI methods to diagnose early tumor spread, providing patients and physicians greater treatment options, including non-surgical alternatives.
 
NEWS
Harnessing the power of technology, the BIO5 Institute will virtually connect University of Arizona faculty and researchers with representatives from biotech, biomedical, and life science companies at the FINE event on Thursday, August 13, 2020.
 
NEWS
Dr. Juanita Merchant, professor and chief of the Division of Gastroenterology and Hepatology, received the 2020 Distinguished Mentor Award from the American Gastroenterological Association. Dr. Merchant is a cancer biology program researcher at the UArizona Cancer Center, an elected member of the National Academy of Medicine and a renowned physician-scientist who has advanced the understanding of gastric response to chronic inflammation and colon cancer. Established in 2004, this mentorship award honors individuals for achievements as outstanding mentors over a lifelong career.
 
NEWS
The androgen receptor is the major driver of prostate cancer growth and survival. However, almost all patients relapse with castration-resistant disease (CRPC) when treated with anti-androgen therapy. Research from Dr. Cindy Miranti, professor of Cellular and Molecular Medicine and Co-Program Leader of the Cancer Biology Research Program, discovered why these traditional therapies have failed in clinical trials to overcome androgen hormone-dependent CRPC.
 
NEWS

The University of Arizona College of Pharmacy has recognized two outstanding faculty members as Educator of the Year for 2020 - one of whom is a BIO5 member.

 
NEWS

Each month, the editors of The American Journal of Human Genetics interview an author of a recently published paper. Dr.

 
NEWS
The University of Arizona will soon begin analyzing blood samples from hundreds of thousands of Arizonans to determine who has been exposed to the virus that causes COVID-19 and developed antibodies against it. The first phase of testing will begin April 30 in Pima County and will include 3,000 health care workers and first responders.